BFLY Overview

Butterfly Network, Inc. is a digital health business offering care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. Its ultrasound devices can perform whole-body imaging with a single handheld probe. Its Ultrasound-on-Chip makes ultrasound accessible outside of healthcare institutions, while its software is intended to make the product fully integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and any hospital computer system. It markets and sells the Butterfly system, which includes probes, related accessories, and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and its e-commerce channel. It licenses its Ultrasound-on-Chip semiconductor platform for co-development of novel technologies through its Embedded program. Its products consist of iQ3, iQ+, iQ+ Bladder, and Compass AI software.

Wall Street analysts forecast BFLY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BFLY is4.25 USD with a low forecast of 4.00 USD and a high forecast of 4.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Butterfly Network Inc revenue for the last quarter amounts to 26.53M USD, increased 24.99

Butterfly Network Inc. EPS for the last quarter amounts to -0.05 USD, decreased -16.67

Butterfly Network Inc (BFLY) has 220 emplpoyees as of July 09 2026.

Today BFLY has the market capitalization of 1.92B USD.